GlassScriptPhysician profile
Paul Gruber
NPI 1134547656
$3,085.80
in general payments reported to CMS, 2019-2025
19 companies · $729 in 2025
The $729 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2021: $45.10 · 2022: $772 · 2023: $474 · 2024: $690 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,808 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,807.54 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $751.49 | 2019-2025 | |
| Janssen Biotech, INC. | $481.57 | 2021-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $293.77 | 2019-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $293.10 | 2021-2025 | Taltz, Ebglyss, Zepbound |
| Organogenesis INC. | $290.77 | 2023-2025 | Simplimax, Puraply |
| Incyte Corporation | $253.70 | 2022-2024 | Opzelura |
| Dermavant Sciences, INC. | $123.96 | 2023 | Vtama |
| Amgen INC. | $118.50 | 2023-2024 | Otezla |
| Genzyme Corporation | $93.14 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $90.85 | 2022-2025 | |
| Acera Surgical, INC. | $83.99 | 2019 | |
| Genentech USA, INC. | $69.43 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $33.66 | 2024 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.43 | 2024 | Siliq |
| Dusa Pharmaceuticals, INC. | $23.33 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $19.36 | 2019 | |
| Kerecis Limited | $15.17 | 2022 | |
| Integra Lifesciences Corporation | $13.76 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mylan Pharmaceuticals INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Gruber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.